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Material and Method: A total of 56 cases of ILC were selected in retrospective review of mammog-
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Results: Asymmetric density was the commonest mammography ﬁnding and the measured sensi-
tivity of mammography in detecting ILC was 87.5% (9/56 FN).The most common US manifesta-
tion of ILC was focal shadowing without a discrete mass and its sensitivity in detecting ILC was
84.9% (10/56 FN). At MR imaging, the most common manifestation of ILC was a solitary irregular
or angular mass with speculated or ill-deﬁned margins (33.9%of cases [n= 19]).The measured sen-
sitivity is 96.5% (2/56 FN). Additional data such as those affected the patient management includ-
ing the presence of multifocal or multicentric disease, chest wall involvement and contralateral breast
cancer were encountered in 48.2% of cases [n= 27]. ILC has a tendency to demonstrate delayed
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Table 1 Mammography appearanc
study group.
Radiological ﬁndings Nu
Mass 12/
Asymmetric density 18/
Architecture distortion 6/
Microcalciﬁcation 11/
Normal 9/
Total 56/
Fig. 1 ‘‘Invasive lobular carcinoma
illdeﬁned hypoechoic mass. (c) Dynam
tumor tissue formed of pleomorphic
ﬁbrosis.
406 N.M. Abdel Razek et al.Conclusion: MR imaging has proved to be superior to mammography and US in the detection and
management of ILC. It provides useful information for further management and pre-surgical plan-
ning.
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Inﬁltrating lobular carcinoma of the breast constitutes about
7–15% of invasive breast cancers (1–4). It presents a diagnostice of 56 cases of ILC in the
mber Percentage
56 21.42
56 32.13
56 10.71
56 19.64
56 16.10
56 100.00
’’: (a) Screening mammography
ic MRM shows intensely enhanc
dyscohesive epithelial cells withchallenge because of its variable presentation on imaging and
clinical examination. It is postulated that the histologic charac-
teristics of inﬁltrating lobular carcinoma are responsible for
the imaging difﬁculties. Typically these tumors show a sin-
gle-ﬁle inﬁltration of malignant cells (1,5,6) through the breast
stroma with a relative paucity of desmoplastic response, hem-
orrhage, necrosis, or calciﬁcation (6). The sensitivities in the
detection of inﬁltrating lobular carcinoma have been reported
as 57–81% for mammography (3,4,7–10) and 68% for sonog-
raphy (3,8). Butler et al. (3) reported sonographic sensitivity of
87%, but they included cases of mixed inﬁltrating lobular car-
cinoma and invasive ductal carcinoma. Contrast-enhanced
MR imaging of the breast is extremely sensitive in the detec-
tion of breast cancer (11–13). Weinstein et al. (14) reported
more extensive tumor burden detection on MR imaging than
on conventional imaging in patients with inﬁltrating lobular
carcinoma.showing asymmetric density. (b) Breast sonography shows a focal
ing speculated outline mass lesion. (d)Histopathology: ILC seen as
hyperchromatic nuclei arranged in Indian Files with surrounding
Fig. 2 ‘‘Invasive lobular carcinoma’’: Screening mammography
showing invisible lesion. Dynamic MRM shows focal nodular
enhancing lesion associated with enhancing septations. The time
intensity curve shows delayed maximum enhancement followed by
wash out.
Dynamic MR-Mammography as the best method for diagnosis of invasive lobular breast carcinoma 4072. Aim of the study
It is a retrospective study aiming to provide diagnostic charac-
terization of ILC in Dynamic MR-Mammography and to
compare its diagnostic performance to mammography and
ultrasonography.
3. Material and Method
A total of 56 cases of ILC were selected in retrospective review
of mammography, ultrasonography and Dynamic MRM of
420 patients with invasive breast cancer who were seen from
January 1, 2007, through October 31, 2010. The pathology
of all cases was available for review.
4. Results
A total of 56 patients out of 420 invasive breast carcinoma
(13.3%) were found to have ILC at histopathology. Among
these 56 patients, the following mammographic manifestations
of ILC were noted (Table 1): Asymmetric density was the com-
monest Mammographic ﬁndings (Fig. 1), it was encountered in
(32.1% [n= 18]), masses (21.4% of cases [n= 12]), microcal-
ciﬁcations (19.6% [n= 11]), architectural distortions (10.7%
[n= 6]), and Normal or benign ﬁndings (16.1% [n= 9]). Thus
the measured sensitivity is 87.5% (9/56 FN), Table 1.
The most common US manifestation of ILC is focal shad-
owing without a discrete mass (23.1% of cases [n= 18]), fol-
lowed by illdeﬁned mass (30.4% of cases [n= 17]), Fig. 1,
followed by irregular or angular mass (19.6% of cases
[n= 11]), followed by lobular well circumscribed mass
(21.4% of cases [n= 12]), followed by sonographically invisi-
ble lesions (17.9% of cases [n= 10]), (Table 2). Thus the mea-
sured sensitivity is 84.9% (10/56 FN).
At MR imaging, the most common manifestation of ILC in
our study group (56 cases) was a solitary irregular or angular
mass with speculated or ill-deﬁned margins (33.9% of cases
[n= 19]), Fig. 1, patchy regional enhancement (33.9% of cases
[n= 19]), and enhancing foci and interconnecting enhancing
strands (28.6% of cases [n= 16]), Fig. 2, Negative MRI was
only encountered in 2 cases (3.6% of cases [n= 2]). Thus the
measured sensitivity is 96.5% (2/56 FN).
Additional data such as those affected the patient manage-
ment including the presence of multifocal or multicentric dis-
ease, Fig. 3, chest wall involvement and contralateral breast
cancer were encountered in 48.2% of cases [n= 27], Table 3.
As regards the kinetic data evaluation, unlike most invasive
breast carcinomas, which demonstrate a classic pattern of rapid
enhancement and washout, ILC has a tendency to demonstrateTable 2 Radiological appearance of 56 cases of ILC in the
study group.
Ultrasound appearance Number Percentage
Acoustic shadowing without a discrete mass 18/56 32.1
Illdeﬁned mass 17/56 30.4
Irregular or angular mass 11/56 19.6
Invisible lesion by US 10/56 17.9
Total 56/56 100.0delayed maximum enhancement, with washout exhibited by
only a minority of lesions (21.4% [n= 12]) Table 3.
5. Discussion
At MR imaging, the most common manifestation of ILC is
speculated enhancing mass. Additional manifestations include
a dominant lesion surrounded by multiple small enhancing
foci, multiple small enhancing foci with interconnecting
enhancing strands, architectural distortions, regional or focal
heterogeneous enhancement, enhancing septa, and normal
ﬁndings (15,19,20). In our study was a solitary irregular or
angular mass with speculated or ill-deﬁned margins (33.9%
of cases [n= 19]), patchy regional enhancement (33.9% of
cases [n= 19]), and enhancing foci and interconnecting
enhancing strands (28.6% of cases [n= 16]), Negative MRI
was only encountered in 2 cases (3.6% of cases [n= 2]). Thus
the measured sensitivity is 96.5% (2/56 FN). These data are
similar to the previous published reports (16,17,19,20).
Unlike most invasive breast carcinomas, which demon-
strate a classic pattern of rapid enhancement and washout,
ILC has a tendency to demonstrate delayed maximum
enhancement, with washout exhibited by only a minority of le-
sions (21.4%) and this was also previously reported in a similar
study (16).
Fig. 3 ‘‘Invasive lobular carcinoma’’ of the left breast lower outer quadrant (white arrow), Dynamic MRM shows additional
information, another mass is seen in the left axillary tail (red arrow) indicating multicentric disease and moreover there is another
enhancing lesion in the lower inner quadrant of the right breast (black arrow) indicating contralateral breast cancer.
Table 3 MRI enhancement pattern of 56 cases of ILC in the
study group.
MRI appearance Number Percentage
Enhancing mass 19/56 33.9
Patchy regional enhancement 19/56 33.9
Enhancing foci and strands 16/56 28.6
Normal ﬁndings 2/56 3.6
Total 56/56 100
Additional ﬁndings on MRI
Multifocal disease 12/56 21.4
Multicentric disease 8/56 14.3
Contralateral disease 5/56 8.9
Chest wall invasion 2/56 3.6
Total 27/56 48.2
Kinetic data
Rapid maximum enhancement 11/56 16.6
Delayed maximum enhancement 27/56 48.2
Continuous rising curve 18/56 32.2
Positive wash out 12/56 21.4
408 N.M. Abdel Razek et al.MR imaging has proved to be a useful adjunct to mammog-
raphy and US in the detection and management of ILC, with a
reported sensitivity of approximately 95% (20). These results
are in agreement with our results, the sensitivity of MRI in
our study is 96.5% (2/56 FN) while the sensitivity of mammog-
raphy alone was 87.5% (9/56FN) and the sensitivity of ultra-
sonography alone was 84.8% (10/56 FN). MR imaging has
been shown to be superior to mammography and US in detect-
ing multifocality and multicentricity, as well as in estimating
tumor size, which tends to be underestimated with conven-
tional imaging (15). A meta-analysis by Mann et al. (16) found
that MR imaging was able to help detect additional ipsilateral
malignant ﬁndings not evident at mammography or US in
32% of ILC patients. In addition, unexpected cancer in the
contralateral breast was seen exclusively at MR imaging in7% of cases (16). Additional ﬁndings were found in 48.2%
of our cases. Most importantly, these additional MR data have
been shown to affect the clinical management of those patients
with ILC, leading to changes in surgical management, likewise
changing from conserving to radical mastectomy and that was
also in accordance with the previously published reports
(16,18,19).
The tendency of ILC to have atypical imaging and clinical
appearances is related to its histopathologic features and its
failure to elicit a desmoplastic response. Despite these
diagnostic challenges, however, imaging remains crucial in
the detection and management of ILC. Mammography, ultra-
sonography, and magnetic resonance (MR) imaging all play
important roles, with each modality having its own advantages
and limitations. The use of MR imaging as adjuncts to mam-
mography and ultrasonography increases sensitivity in the
detection of ILC and provides useful information for further
management and pre-surgical planning.6. Conclusion
MR imaging has proved to be a useful superior to mammog-
raphy and US in the detection and management of ILC. It pro-
vides useful information for further management and pre-
surgical planning.References
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